Rentokil Initial plc (LON:RTO - Get Free Report) shares shot up 9.1% during trading on Thursday . The stock traded as high as GBX 387.30 ($5.14) and last traded at GBX 377.98 ($5.02). 13,367,716 shares were traded during trading, an increase of 30% from the average session volume of 10,266,272 shares. The stock had previously closed at GBX 346.60 ($4.60).
Analyst Upgrades and Downgrades
Several research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft lifted their target price on Rentokil Initial from GBX 425 ($5.64) to GBX 435 ($5.78) and gave the company a "buy" rating in a research note on Monday, July 21st. Royal Bank Of Canada restated an "outperform" rating and issued a GBX 440 ($5.84) price target on shares of Rentokil Initial in a research note on Friday.
Read Our Latest Stock Report on RTO
Rentokil Initial Stock Performance
The stock has a 50 day moving average of GBX 353.10 and a two-hundred day moving average of GBX 359.12. The stock has a market capitalization of £8.87 billion, a PE ratio of 22.73, a P/E/G ratio of 0.56 and a beta of 0.55. The company has a debt-to-equity ratio of 113.35, a current ratio of 1.04 and a quick ratio of 1.76.
Insider Transactions at Rentokil Initial
In other news, insider Sally Johnson acquired 3,567 shares of Rentokil Initial stock in a transaction that occurred on Monday, June 2nd. The stock was purchased at an average cost of GBX 351 ($4.66) per share, with a total value of £12,520.17 ($16,624.84). Corporate insiders own 0.32% of the company's stock.
Rentokil Initial Company Profile
(
Get Free Report)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Featured Articles
Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access